A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's Syndrome
Public ClinicalTrials.gov record NCT02701985. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase 2A Study to Assess the Efficacy of RO5459072 in Patients With Primary Sjogren's Syndrome
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, double-blind, placebo-controlled, two-treatment arm, parallel-group study designed to evaluate the effects of RO5459072 treatment on disease activity and symptoms of Sjogren's syndrome in adult participants with moderate to severe primary Sjogren's syndrome. The total duration of the study for each participant will be approximately 18 weeks (including screening).
Study identification
- NCT ID
- NCT02701985
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 75 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 5, 2016 (Actual)
- Primary completion
- Jul 10, 2017 (Actual)
- Completion
- Jul 10, 2017 (Actual)
- Last update posted
- Aug 1, 2018
2016 – 2017
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Wallace Rheumatic Study Center | Beverly Hills | California | 90211 | — |
| Denver Arthritis Clinic | Denver | Colorado | 80230-7127 | — |
| Ochsner Clinic Foundation | Baton Rouge | Louisiana | 70809 | — |
| John Hopkins Bayview Medical Center | Baltimore | Maryland | 21224 | — |
| University Of Michigan | Ann Arbor | Michigan | 48109 | — |
| Winthrop University Hospital | Mineola | New York | 11501 | — |
| Shanahan Rheumatology & Immunology, PLLC | Raleigh | North Carolina | 27617 | — |
| MetroHealth System | Cleveland | Ohio | 44109 | — |
| Altoona Center For Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| Clinical Research Center of Reading | Wyomissing | Pennsylvania | 19610 | — |
| Ramesh Gupta - PP | Memphis | Tennessee | 38119 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02701985, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 1, 2018 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02701985 live on ClinicalTrials.gov.